The ectopic introduction of RBM5 can induce the apoptosis of human prostate cancer PC-3 cells by modulating the mitochondrial apoptotic pathway, and thus RBM5 may be a promising target for gene therapy on prostate cancer. Here, RBM5 is linked to prostate carcinoma.